↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.0MSold on the market
1Companies
Oct 5, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202617:36 | Oct 1, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | S · Sell10b5-1 | $24.47 | −27,000 | 115,743 | -19% | −$661K | ||
| Oct 5, 202617:36 | Oct 1, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | M · Exercise10b5-1 | $5.20 | +27,000 | 142,743 | +23% | $140K | ||
| Sep 3, 202616:01 | Sep 1, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | S · Sell10b5-1 | $22.37 | −27,000 | 115,743 | -19% | −$604K | ||
| Sep 3, 202616:01 | Sep 1, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | M · Exercise10b5-1 | $5.20 | +27,000 | 142,743 | +23% | $140K | ||
| Aug 5, 202616:01 | Aug 3, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | S · Sell10b5-1 | $27.24 | −27,000 | 115,743 | -19% | −$736K | ||
| Aug 5, 202616:01 | Aug 3, 2026 | TNGXTango Therapeutics, Inc. | President, R&D | M · Exercise10b5-1 | $5.20 | +27,000 | 142,743 | +23% | $140K |